01 · FUNDABLE
Investor-Ready Foundations
Arrive at your CDMO and your investors with the answers before the questions are asked.
Investors and CDMOs start their industrial due diligence. Gaps in CMC, quality system or data integrity cost weeks, credibility and valuation.
For whom. Clinical-stage biotechs (Phase 1–3), choosing a first CDMO or a second site, before a funding round or a deal.
What we do
- CMC and manufacturability, from lab to GMP scale
- Quality readiness: QMS, data integrity, Quality Transfer Package
- CDMO selection: 2–3 candidates, geography and tariff tier included
- Manufacturing narrative for investors
BOARD KPI
Transfer on schedule; manufacturing section of the data room complete.